Article Details
Retrieved on: 2024-01-30 19:57:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Trastuzumab deruxtecan currently has FDA approval as a second-line treatment for the treatment of certain patients with relapsed or refractory (R/R) ...
Article found on: www.ajmc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here